Werewolf Therapeutics Stock Forecast

HOWL's stock price has decreased by -70.05% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Werewolf Therapeutics stock have an average target of $4.00, which predicts a 919.63% increase from the current stock price of 0.39.

Price Target: $4.00 (+919.63%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$4.00	$4.00	$4.00
Change	+919.63%	+919.63%	+919.63%	+919.63%

* Price targets were last updated on Feb 17, 2026.

Analyst Ratings

The average analyst rating for Werewolf Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	5	4	4	4	3	2
Buy	1	0	0	0	0	0
Hold	0	2	1	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	5	4	3	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Zemansky Bank of America Securities	Bank of America Securities	Buy Reiterates $7	Buy	Reiterates	$7	+1,684.35%	Feb 17, 2026
Reni Benjamin Citizens JMP	Citizens JMP	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Dec 19, 2025
Robert Driscoll Wedbush	Wedbush	Hold Downgrades $3 → $1	Hold	Downgrades	$3 → $1	+154.91%	Dec 19, 2025
Andres Y. Maldonado H.C. Wainwright	H.C. Wainwright	Buy Reiterates $10 → $4	Buy	Reiterates	$10 → $4	+919.63%	Dec 19, 2025

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.89

from -1.32

EPS Next Year

-0.99

from -0.89

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	16.40M	19.94M	1.89M	-	-
Operating Income	-50.09M	-56.06M	-40.50M	-73.59M	-60.68M	-46.40M
Net Income	-49.98M	-53.81M	-37.37M	-70.52M	-60.82M	-46.40M
EPS	-	-	-	-	-1.32	-0.89
Free Cash Flow	-24.49M	-26.18M	-22.16M	-34.04M	-40.27M	-45.71M
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.89
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-